Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Pelcitoclax | 1619923-36-2 | 99.7% | 1281.85 | 10 MG
Supplier: Medchemexpress LLC HY10918510MG
Pelcitoclax (APG-1252) is a potent Bcl-2/Bcl-xl inhibitor with antineoplastic and pro-apoptotic effects. It is for research use only. In vitro, APG-1252 changes to a reactive metabolite named APG-1252-M1, which has remarkable antitumor effects in acute myeloid leukemia. In vivo, Pelcitoclax (APG-1252) treatment inhibits xenograft tumor growth.
- Potent Bcl-2/Bcl-xl inhibitor
- Antineoplastic and pro-apoptotic effects
- Changes to reactive metabolite APG-1252-M1 with antitumor effects in acute myeloid leukemia
- Inhibits xenograft tumor growth in vivo
- Solid appearance
- White to off-white color
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?